Ameriprise’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,588
Closed -$14K 3959
2023
Q1
$14K Sell
2,588
-7
-0.3% -$38 ﹤0.01% 3905
2022
Q4
$18K Buy
2,595
+7
+0.3% +$49 ﹤0.01% 3893
2022
Q3
$20K Sell
2,588
-1,324
-34% -$10.2K ﹤0.01% 3915
2022
Q2
$53K Hold
3,912
﹤0.01% 3824
2022
Q1
$91K Hold
3,912
﹤0.01% 3851
2021
Q4
$66K Sell
3,912
-19,970
-84% -$337K ﹤0.01% 3893
2021
Q3
$443K Sell
23,882
-11,883
-33% -$220K ﹤0.01% 3442
2021
Q2
$851K Sell
35,765
-5,529
-13% -$132K ﹤0.01% 3282
2021
Q1
$1.06M Sell
41,294
-1,824
-4% -$46.8K ﹤0.01% 3121
2020
Q4
$997K Sell
43,118
-3,117
-7% -$72.1K ﹤0.01% 3089
2020
Q3
$1.11M Sell
46,235
-147
-0.3% -$3.52K ﹤0.01% 2922
2020
Q2
$994K Sell
46,382
-90
-0.2% -$1.93K ﹤0.01% 2916
2020
Q1
$269K Buy
46,472
+15,860
+52% +$91.8K ﹤0.01% 3339
2019
Q4
$200K Sell
30,612
-4,294
-12% -$28.1K ﹤0.01% 3575
2019
Q3
$1.66M Buy
34,906
+1,162
+3% +$55.3K ﹤0.01% 2782
2019
Q2
$1.12M Sell
33,744
-7,574
-18% -$251K ﹤0.01% 3009
2019
Q1
$1.62M Buy
41,318
+8,059
+24% +$317K ﹤0.01% 2833
2018
Q4
$721K Buy
33,259
+18,877
+131% +$409K ﹤0.01% 3062
2018
Q3
$337K Buy
14,382
+4,882
+51% +$114K ﹤0.01% 3412
2018
Q2
$210K Buy
9,500
+6
+0.1% +$133 ﹤0.01% 3466
2018
Q1
$247K Sell
9,494
-59
-0.6% -$1.54K ﹤0.01% 3407
2017
Q4
$559K Buy
9,553
+59
+0.6% +$3.45K ﹤0.01% 3168
2017
Q3
$641K Buy
9,494
+341
+4% +$23K ﹤0.01% 3129
2017
Q2
$626K Buy
9,153
+1,412
+18% +$96.6K ﹤0.01% 3143
2017
Q1
$513K Buy
7,741
+3,859
+99% +$256K ﹤0.01% 3156
2016
Q4
$243K Sell
3,882
-59
-1% -$3.69K ﹤0.01% 3572
2016
Q3
$299K Sell
3,941
-6
-0.2% -$455 ﹤0.01% 3387
2016
Q2
$204K Sell
3,947
-7,700
-66% -$398K ﹤0.01% 3523
2016
Q1
$2.01M Sell
11,647
-922
-7% -$159K ﹤0.01% 2497
2015
Q4
$2.76M Buy
12,569
+406
+3% +$89.3K ﹤0.01% 2424
2015
Q3
$2.45M Buy
12,163
+4,763
+64% +$958K ﹤0.01% 2491
2015
Q2
$1.08M Buy
7,400
+2,694
+57% +$393K ﹤0.01% 3067
2015
Q1
$552K Buy
+4,706
New +$552K ﹤0.01% 3164